LABP
Landos Biopharma, Inc.
No insider bought or sold Landos Biopharma, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
LABP over the last year
Prices for LABP aren't in yet.
LABP after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
11 insider filings since 2021, newest first
LABPSell
Rtw Investments, LP · 10% owner
$207K−7.0%Sep 27
LABPSell
Josep Bassaganya-Riera · 10% owner
$456K−1.0%Dec 20
LABPSell
Josep Bassaganya-Riera · 10% owner
$645K−2.0%Dec 15
LABPSell
Josep Bassaganya-Riera · 10% owner
$301K−1.0%Dec 10
LABPSell
Josep Bassaganya-Riera · 10% owner
$640K−1.0%Dec 3
LABPSell
Josep Bassaganya-Riera · 10% owner
$364K−1.0%Dec 1
LABPBuy
Perceptive Advisors LLC · Director and 10% owner
$3.2M+1.0%Feb 9
LABPBuy
Konstantin Poukalov · Director and 10% owner
$3.2M+2.0%Feb 9
LABPBuy
Perceptive Advisors LLC · Director and 10% owner
$20.0M+14.0%Feb 8
LABPBuy
Konstantin Poukalov · Director and 10% owner
$20.0M+9.0%Feb 8
LABPBuy
Rtw Investments, LP · 10% owner
$10.0M+17.0%Feb 8
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.